Skip to main content
Fig. 4 | Diagnostic Pathology

Fig. 4

From: Expression of FAM83H and ZNF16 are associated with shorter survival of patients with gallbladder carcinoma

Fig. 4

Survival analysis according to the individual and co-expression patterns of nuclear FAM83H and nuclear ZNF16 in 23 gallbladder carcinoma patients who received adjuvant chemotherapy. a Survival analysis for overall survival and relapse-free survival according to the expression of nuclear FAM83H (nFAM83H). b Survival analysis for overall survival and relapse-free survival according to expression of nuclear ZNF16 (nZNF16). c Survival analysis in two prognostic groups of gallbladder carcinomas according to co-expression patterns of nuclear FAM83H and nuclear ZNF16: [nFAM83H−/nZNF16−] and [nFAM83H−/nZNF16+, nFAM83H+/nZNF16− or nFAM83H+/nZNF16+] subgroups

Back to article page

Diagnostic Pathology

ISSN: 1746-1596

Contact us